FDA Approves New Treatment for Acute Lymphoblastic Leukemia

Share this content:
FDA Approves New Treatment for Acute Lymphoblastic Leukemia
FDA Approves New Treatment for Acute Lymphoblastic Leukemia

THURSDAY, Aug. 17, 2017 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved Besponsa (inotuzumab ozogamicin) to treat B-cell acute lymphoblastic leukemia (ALL).

Besponsa was evaluated in clinical studies involving 326 patients with relapsed or refractory B-cell ALL who had received one or two prior treatments with other medication. After taking Besponsa, 35.8 percent of patients evaluated achieved complete remission for about eight months, compared with 17.4 percent of those who took a different chemotherapy drug.

Common side effects of Besponsa included thrombocytopenia, neutropenia, leukopenia, infection, anemia, fatigue, and severe bleeding. The drug's label includes a boxed warning of possible severe liver damage. Pregnant or breastfeeding women shouldn't take Besponsa, the FDA said.

"For adult patients with B-cell ALL whose cancer has not responded to initial treatment or has returned after treatment, life expectancy is typically low," Richard Pazdur, M.D., director of the FDA's Oncology Center of Excellence, said in a statement. "These patients have few treatments available and today's approval provides a new, targeted treatment option."

Approval was granted to Pfizer, based in New York City.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Air Pollution May Damage Kidneys

Air Pollution May Damage Kidneys

Study finds link between particulate matter and renal function

Diabetes Treatment Failure May Actually Be Nonadherence

Diabetes Treatment Failure May Actually Be Nonadherence

Second-line treatment often initiated without evidence of recommended use of first-line treatment

Effect of Osteoporotic Fractures Similar to Diabetes Burden

Effect of Osteoporotic Fractures Similar to Diabetes Burden

Findings for quality of life with hip fractures, vertebral compression vs. vision loss, amputation

is free, fast, and customized just for you!

Already a member?

Sign In Now »